StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
No sell-side coverage available for NAKA yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-15 | $0.18 | $0.19 | +1.90% | 5.4M |
| 05-18 | $0.18 | $0.17 | -8.11% | 3.6M |
| 05-19 | $0.17 | $0.17 | -2.46% | 2.9M |
| 05-20 | $0.15 | $0.16 | +5.55% | 10.6M |
| 05-21 | $0.16 | $0.17 | +6.02% | 6.3M |
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
Nakamoto Inc is a Bitcoin company building a world-wide portfolio of Bitcoin-native companies to provide commercial and financial infrastructure for the next generation of capital markets. The firm has two principal business segments: Bitcoin Operations, which houses its Bitcoin treasury and is utilized to support investments in other Bitcoin-related companies; Healthcare Operations, which provides a patient-focused healthcare experience that provides patients personalized solutions in order to reduce opioid use and improve health outcomes. The company generates the majority of its revenue from the Healthcare Operations.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.68M | $1.82M | $1.38M | $988.18K |
Operating Income | $-126.17M | $-197.14M | $-13.84M | $-3.43M |
Net Income | $-238.78M | $-52.23M | $-89.49M | $-2.41M |
EPS (Diluted) | $-0.38 | $-0.26 | $-1.24 | $-0.54 |
Total Assets | $620.76M | $730.61M | $692.42M | $9.89M |
Total Liabilities | $253.69M | $216.35M | $214.86M | $923.39K |
Cash & Equivalents | $35.30M | $22.58M | $24.19M | $6.02M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 690.02M | 437.95M | 427.15M | 7.58M |
Latest Form 13F-HR disclosures from the curated Super Investors list. Click through to see each manager's full long book.